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INTRODUCTION
There has been an increase in the number of reported cases
of group A streptococci (GAS) sepsis recently (1). The number
of severe GAS infections, such as toxic shock-like syndrome
(TSLS), also has increased in many countries, reflecting chang-
ing epidemiology and clinical patterns of invasive streptococ-
cal infections (2-5). International communications about dis-
ease and strain typing are important in defining and monitor-
ing trends in infectious diseases (6). The M protein and strep-
tococcus pyrogenic exotoxin (SPE A) are the most important
virulence factors in GAS infections. An increasing frequency
of M serotypes 1 and 3 has been observed in the United States
(7) and Europe (8). These types are more often involved in
invasive and fatal infections than are other M serotypes (2, 9). 
Although M typing has long been used for epidemiologic
purpose, it is difficult to perform routinely because it is hard
to produce and maintain more than 80 kinds of anti-M sera.
Recently, genetic typing of GAS became available through
the sequencing of the 5′ N-terminal end of the emm gene,
which encodes the M protein (10, 11). However, emm typing
might not adequately reflect the genetic diversity of bacte-
rial strains, as suggested by the finding that strains express-
ing the same M serotype can be distinguished by pulsed-field
gel electrophoresis (PFGE) (6, 12). 
In this work, genetic variability of GAS strains isolated
from patients with sepsis was determined by emm genotyp-
ing and PFGE. Restriction-fragment length polymorphism
(RFLP) analysis of emm PCR products was applied for the
simple discrimination of each strain. The presence of speA and
the production of SPE A were also examined to estimate the
positive rate of this toxin in GAS sepsis.
MATERIALS AND METHODS
Bacterial strains
A total of 28 GAS strains isolated from blood cultures
from 1992 through 1999 were collected from four universi-
ty hospitals: Seoul National University Hospital (17 strains),
Asan Medical Center (4 strains), Ewha University Mokdong
Hospital (1 strain), all located in Seoul, and Gyeongsang
National University Hospital (6 strains), located in Jinju.
The medical records were reviewed for all patients, with note
taken of age, sex, underlying diseases, the presence of TSLS,
and the clinical outcome. There were 28 patients with a medi-
an age of 51 yr (range 1 month-74 yr), of whom 38.5% were
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The M protein and streptococcus pyrogenic exotoxin (SPE A) are important viru-
lence factors in group A streptococci (GAS) infections. The emm types of GAS
strains isolated from patients with sepsis were determined by sequencing the 5′
N-terminus of the emm gene, encoding the M protein, and clonality analysis using
pulsed-field gel electrophoresis. The presence of speA and production of SPE A
were also examined. There were no predominant GAS clones. The emm geno-
types were variable, and the most common genotype was emm13 (17.9%). The
production prevalence of SPE A was 21.4%. The low mortality rate (7.1%) of GAS
sepsis might be attributable to the low incidence of virulent strains such as emm1
(10.7%) and emm3 (7.1%), as well as to low production rate of SPE A.
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15 yr or younger and 23.1% were older than 60 yr. Nine
patients had cancer. The sources of sepsis were cellulitis in 4
cases, pneumonia in 3, and peritonitis in 2. In 11, no focus
of infection could be identified. All but 2 patients of TSLS
survived (Table 1).
For identification of GAS,  -hemolytic colonies on sheep
blood agar plate were tested with bacitracin, latex aggluti-
nation (Strepto LA kit; Denka Seiken, Tokyo, Japan), and
the VITEK GPI card (bioMeriux, Hazelwood, MO, U.S.A.).
T typing
All 28 isolates were tested for T type by slide agglutina-
tion (Sevac AS, Prague, Czech Republic).
emm genotyping
The emm sequence analysis method was modified from that
of Beall et al. (11). Forward and backward primers were used
in PCR as described previously (12). The product was sequ-
enced using primer 5′ -TATTCGCTTAGAAAATTAAAA-
ACAGG-3′ (13) with dye-labeled terminator PCR mix and
subjected to automated sequence analysis on a 373 Autose-
quencer (Applied Biosystems, Foster City, CA, U.S.A.). The
DNA sequences were subjected to homology searches against
the bacterial DNA database with the BLAST program from
the U.S. National Center for Biotechnology Information.
The corresponding emm sequence diverged by less than 4%
over 150 to 200 bases.
The emm PCR products were cut with HaeIII and separat-
ed on 12% polyacrylamide gel for 2 hr at 15 mA. Gels were
stained with ethidium bromide and photographed (Polaroid
667 film) under UV light.
PFGE
Macrorestriction and PFGE were performed as previously
described with several modifications (2). Genomic DNA was
digested with SmaI or ApaI for 6 hr at 25℃. Fragments of
DNA were separated on 1% pulsed field-certified agarose
(Bio-Rad, Hercules, CA, U.S.A.) in 0.5× TBE buffer using
a CHEF-Mapper XA system (Bio-Rad) for 27 hr with a 2.16-
to 26.29-sec switch time and 74% ramping factor between
10 and 700 kb at a 120°angle and 6 V/cm. Gels were stained
with ethidium bromide, rinsed in distilled water, and pho-
tographed under UV light.
Detection of speA and SPE A
The PCR primers were used for detection of speA as pre-
viously described (16). Initial denaturation of DNA at 94℃
for 3 min was followed by 30 cycles of 94℃for 1 min, 50℃
for 1 min, and 72℃ for 1 min. The amplicon size for speA
was 205 bp.
The bacterial suspension was precipitated with ethanol,
mixed with loading buffer, and boiled for 5 min. The dena-
tured protein was separated on 10% polyacrylamide gel for
1.5 hr at 16 mA. The gel was transferred to the nitrocellulose
membrane for 15 hr at 80 mA, and the membrane was treated
with anti-SPE A antibody. Color development was observed
with anti-rabbit antibody and 4-chloro-1-naphthol.
RESULTS
There were three (10.7%) strains each of the T1, T12, and
T28 types (Table 2). Ten strains (35.7%) were nontypeable.
Two strains showed a rare combination of T and emm types,
namely SJ8 (T6, emm13) and SJ21 (T4, emm2).
Strain 
No.
Isolation
time
Hos-
pital
Sex
Age
(yr)
Out-
come
Underlying disease
SJ-1 96.5 A M 36 LC, varix bleeding Alive
SJ-2 96.5 A M 11 Sepsis, lymphangitis �
SJ-3 96.7 A M 59 LC, PLCa �
SJ-4 96.12 A F 71 Cervix Ca, psoas abscess �
SJ-5 97.1 A M 63 PLCa �
SJ-6 97.2 A M 1 Omphalitis �
SJ-7 97.4 A F 6 Angina, pharyngitis �
SJ-8 98.7 A F 56 Cervix Ca �
SJ-9 97.5 A M 42 Chronic hepatitis �
SJ-10 97.6 A F 53 Cervix Ca, bacterial  �
meningitis
SJ-11 98.4 A F 11 SLE, FUO �
SJ-12 95.7 B F 74 SCLCa, neutropenic fever �
SJ-13 95.6 B M 63 Pharyngitis, cellulitis �
SJ-14 96.11 B M 51 AGCa, intestinal obstruction �
SJ-15 95.7 B M 15 Right foot cellulitis �
SJ-16 92.3 A M 9 Spontaneous bacterial  �
peritonitis
SJ-17 97. 2 C F 32 Pregnancy, IUFD, TSLS DoD
SJ-18 95.7 D M 55 Diabetic foot Alive
SJ-19 D Not available
SJ-20 95.3 D M 62 Duodenal Ca, peritonitis Alive
SJ-21 98.9 D M 56 Cellulitis, TSLS DoD
SJ-22 95.1 A M 9 ALL Alive
SJ-23 96.10 A M 5 Brain stem glioma,  �
pneumonia
SJ-24 97.10 A F 1 Omphalitis, neonatal sepsis �
SJ-25 93.1 A F 1 Pneumonia, neonatal sepsis �
SJ-26 99.3 A M 60 Deep vein thrombosis �
SJ-27 99.1 D M 57 Diabetic foot, cellulitis �
SJ-28 99.1 D M 55 Aspiration pneumonia �
Table 1. Clinical features of 28 cases of group A streptococcal
bacteremia
Hospitals: A, Seoul National University Hospital; B, Asan Medical Center;
C, Ehwa Woman’s University Mokdong Hospital; D, Gyeongsang National
University Hospital.
LC, liver cirrhosis; PLCa, primary liver cancer; SLE, systemic lupus ery-
thematosus; FUO, fever of unknown origin; SCLCa, small-cell lung can-
cer; AGCa, advanced gastric cancer; IUFD, intrauterine fetal death;
DoD, died of streptococcal disease; TSLS, toxic shock-like syndrome;
DM, diabetes mellitus; ALL, acute lymphocytic leukemia. Genetic Diversity of Group A Streptococci Causing Sepsis 195
The most frequent emm type was 13 (17.9%). The next
most common types were emm12 (14.3%), emm1 (10.7%),
and emm28 (10.7%). There were 13 emm-types (Table 2).
One to three small fragments were separated on the gel
after treatment with HaeIII (Fig. 1A). All strains except emm6
were digested with HaeIII and were classified into seven types
(Fig. 1B). The emm49, emm53, and SP2346 types demonstrated
similar RFLP patterns (H1) with emm1. The emm 2, 22, and
28 types also showed similar RFLP patterns (H2). Otherwise,
each emm type had a unique RFLP pattern (Table 2). 
All but 4 of the 28 strains were digested with SmaI, show-
ing 10 to 15 large fragments (Fig. 2A). Two strains of emm75,
one of emm6, and one of emm12 were not digested with SmaI,
whereas they were cut with ApaI (Fig. 2B). The emm13, 12,
and 1 types showed some variance of PFGE pattern. Otherwise,
each emm type had a unique PFGE pattern. Thirteen PFGE
patterns were found by SmaI (Fig. 3). All strains were cut
with ApaI, and the genetic diversity revealed by ApaI agreed
with the result of SmaI digestion. Exceptionally SJ6 and SJ8
(emm13) showed 3 different fragment bands with ApaI, while
they were the same with SmaI enzyme. 
The presence of speA and SPE A toxin was found only in
the emm1, emm3, and SP2346 strains (Table 2).
DISCUSSION
GAS have long been recognized as serious human pathogens
Fig. 1. (A) emm-RFLP restricted with HaeIII enzyme runned on 12% acrylamide gel and (B) its schematic pattern. Number of each lane in
(B) represents emm RFLP pattern. Lane M, molecular marker of 100 bp ladder.
1 28 75 4 1 13 6 13 28 emm types
M 1 23 45 678 9 Strains (SJ)
B
M1 2 3 4 5 6 7
Fig. 2. Genomic DNA fingerprints by pulsed-field gel electrophoresis after digestion with (A) SmaI and (B) ApaI enzymes. Lane M, molec-
ular marker of low range PFG.
A
1 28 75 4 1 13 6 13 28 emm types
1M23 4 56 7 89 M Strains (SJ)
B
1 28 75 4 1 13 6 13 28 emm types
M1 23 4 56 7 89 M Strains (SJ)
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that cause life-threatening illnesses such as sepsis (1), rheumatic
fever (RF), necrotizing fasciitis (16), and TSLS (3-5). Sepsis
cases attributable to GAS had arisen sporadically in Korea
(3, 12). In the U.S.A., 64% of GAS sepsis cases between 1989
and 1990 were caused by M1 serotype, compared with 18%
of those before 1979 (17). More than 80% of the GAS isolat-
ed from patients with severe disease produce SPE, as opposed
to less than 20% of isolates causing less serious disease (17).
The M1 and M3 strains may be more likely to cause inva-
sive infections (8). The SPE A protein, an inherent virulence
factor, plays an important role in TSLS (5-7, 18). The emm1
and emm3 strains producing SPE A represented only 17.9%
of the isolates in this study, which may explain the good out-
comes of sepsis.
Both T and M typing have been used for surveillance and
other epidemiologic studies. As anti-T sera have become
commercially available, T typing has been widely used for
screening for epidemiologic studies of GAS infections (14).
We performed T typing, expecting high typeability, as we
had already experienced more than 90% typeability for GAS
strains isolated from throat cultures (19). However, the pro-
portion of T-nontypeable strains was so high (35.7%) in this
study that T typing was only partly helpful in classifying the
isolates. Rare combinations of T and emm type were observed
in two strains (T6, emm13; T4, emm2) (14, 20). The M1 and
M3 strains are known to have caused the recent outbreaks of
RF and TSLS (2, 4-7, 17). Although the study period is dif-
ferent, the previous studies of the prevalence of M types in
school children showed that M1 (1.2%) and M3 (4.9%) were
rare, while M12 (48.8%) and M5 (14.6%) were very common
(n=82) in Seoul. The M1 (3.9%) and M3 (1.3%) strains
were likewise rare, while M12 (26.3%), M22 (14.5%), and
M28 (10.5%) were frequent (N=76) in Jinju (19). Although
emm13 was the most common type in this study, it was not
found in school children in Seoul and was recovered only
from 2.6% of school children in Jinju (19). Another study
revealed emm1 (20.1%) and emm3 (7.7%) were not uncom-
mon in the clinical isolates of GAS in Seoul (12). No emm13
was identified among 194 clinical isolates (12). The authors
demonstrated the difference of emm distribution between
school children and the patients with acute pharyngitis in
the same area (21). The M types corresponding to emm53 and
SP2346 have not been identified previously in Korea (19,
22). An emm sequence analysis has the advantage of being
able to differentiate serologically M-nontypeable strains and
to identify new emm genes (11).
The emm-RFLP technique is easy and economical for epi-
demiologic studies (15) and is a rapid method of sorting large
numbers of diverse GAS into distinct genotypes. The emm-
RFLP method can be used as an alternative to emm sequence
typing or PFGE in a small laboratory. The emm-RFLP analy-
sis is applicable to areas where GAS are endemic and where
the majority of isolates are M nontypeable by serotyping (23).
Fig. 3. Schematic pattern of each representative fingerprints pro-
duced by SmaI enzyme. Marker, molecular marker of low range
PFG.
A
B
C
D
E
F1
F2
F3
G
H
I
J
K
L1
L2
M
Marker
emm-3
emm-6
emm-28
emm-13
SP2346
emm-12
emm-12
emm-12
emm-22
emm-13
emm-4
emm-53/67
emm-49
emm-1
emm-1
emm-2
Strain 
No.
emm
genotype
emm-
RFLP
PFGE
pattern
speA
gene
T type
SPE A
toxin
SJ-1 1 1 H1-a L1 + +
SJ-5 1 1 H1-a L2 + +
SJ-14 1 1 H1-a L1 + +
SJ-21 4 2 H2-c M - -
SJ-12 3 3 H6 A + +
SJ-17 3/B3264 3 H6 A + +
SJ-4 NT 4 H4 I - -
SJ-10 4 4 H4 I - -
SJ-7 6 6 Uncut B - -
SJ-19 6 6 Uncut Uncut - -
SJ-15 12/27 12 H7 F3 - -
SJ-16 12 12 H7 F2 - -
SJ-26 NT 12 H7 Uncut - -
SJ-27 12 12 H7 F1 - -
SJ-6 NT 13 H5 D - -
SJ-8 6 13 H5 D - -
SJ-13 NT 13 H5 D - -
SJ-20 NT 13 H5 H - -
SJ-22 NT 13 H5 D - -
SJ-18 12 22 H2-c G - -
SJ-2 28 28 H2-a C - -
SJ-9 28 28 H2-b C - -
SJ-23 28 28 H2-a C - -
SJ-24 NT 49 H1-b K - -
SJ-28 NT 53 H1-b J - -
SJ-3 NT 75 H3 Uncut - -
SJ-11 NT 75 H3 Uncut - -
SJ-25 B3264 SP2346 H1-b E + +
Table 2. T type, emm genotype, emm-RFLP, PFGE pattern, and
presence of speA and production of SPE A of group A strepto-
cocci isolated from blood
NT, Nontypeable.Simple discrimination of the strains into seven groups was
possible by emm-RFLP. Identical emm restriction cleavage
profiles had the same emm gene sequences except for a few
types. The emm49, emm53, SP2346 strain could not be dif-
ferentiated from emm1 by emm-RFLP, as is also true of emm2,
emm22, and emm28. Two strains of the emm6 type were not
cut with HaeIII, which suggests the limitation of emm-RFLP
for epidemiologic studies.
It is notable that the clones of the same emm types were main-
tained over different areas/hospitals for a long periods of time.
Although there was no predominant clone, six small clusters
of clones (emm 1, 3, 4, 12, 13, and 28) were found by PFGE
(Table 2). Differences in PFGE patterns were noted within
the same emm13 type. Two strains of emm75 and one each of
emm6 and emm12 were not cut by SmaI despite repeated exper-
iments. These strains were, however, digested with ApaI, sug-
gesting DNA integrity during the PFGE procedure. Recently,
there have been reports that strains carrying the macrolide
resistance gene, mefA, are not cut with SmaI (24, 25). This
gene may encode a SmaI site-modifying activity (25). Those
strains uncut with SmaI in this study were confirmed to have
the mefA gene by PCR (unpublished data). 
The SmaI digests of chromosomal DNA of two emm3 strains
appeared to have PFGE profiles identical to that of the PFGE-1
clone found in a study of invasive streptococcal disease in
Minnesota (26). Although PFGE-1 clone serotyped M3 pre-
dominated in TSLS in the U.S.A. (26) and in Japan (27), it
represented only 7.1% of our isolates. Notably one emm3 strain
(SJ17) caused TSLS in this study. On the other hand, the
findings of Chaussee et al. (28) did not support a clonal basis
for the resurgence of invasive streptococcal infections by ob-
serving the genetic heterogeneity using PFGE. There might
be no predominant emm type or PFGE pattern, because the
GAS strains had been isolated sporadically over several years
at four hospitals in this study. Drawbacks of this study are
lack of evaluation of invasiveness or virulence of GAS isolates
and limited number of cases. Following studies with enough
number of cases are needed.
In conclusion, there were several small clusters of clones
found among the GAS strains causing sepsis by T typing,
emm, emm-RFLP and PFGE profiles. The emm types of the
GAS isolated were variable, and the most common type was
emm13. The production of SPE A was associated with emm1
and emm3 types. The proportion of SPE A-producing GAS
was relatively low, which may explain the good prognosis of
GAS sepsis in this study. 
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